BRAINSTORM CELL THERAPEUTICS INC. Loss Contingency, Damages Sought, Value
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Loss Contingency, Damages Sought, Value of ILS 2.12 billion as of 2026-06-18, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Commitment and Contingencies › Loss Contingency › Loss Contingency, Information about Litigation Matters
us-gaap:LossContingencyDamagesSoughtValue · last filed 2026-08-14
- 2026-06-18: Loss Contingency, Damages Sought, Value 2.12B ILS.
ILS
| Period end | Loss Contingency, Damages Sought, Value |
|---|---|
| 2026-06-18 | 2.12B ILS 10-Q · filed 2026-08-14 |
USD
| Period end | Loss Contingency, Damages Sought, Value |
|---|---|
| 2026-06-18 | $700.00K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |